Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms

REFERENCES

• Abraham, D., K. Podar, M. Pacher, M. Kubicek, N. Welzel, B. A. Hemmings, S. M. Dilworth, H. Mischak, W. Kolch, and M. Baccarini. 2000. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275: 22300–22304.
   PubMed Web of Science ®Google Scholar
• Ally, S., T. Clair, D. Katsaros, G. Tortora, H. Yokozaki, R. A. Finch, T. L. Avery, and Y. S. Cho-Chung. 1989. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res. 49: 5650–5655.
   PubMed Web of Science ®Google Scholar
• Avruch, J., A. Khokhlatchev, J. M. Kyriakis, Z. Luo, G. Tzivion, D. Vavvas, and X. F. Zhang. 2001. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog. Horm. Res. 56: 127–155.
   PubMedGoogle Scholar
• Bos, J. L., J. de Rooij, and K. A. Reedquist. 2001. Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2: 369–377.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201: 110–149.
   PubMed Web of Science ®Google Scholar
• Burgering, B. M. T., G. J. Pronk, P. van Weeren, P. Chardin, and J. L. Bos. 1993. cAMP antagonizes p21ras directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12: 4211–4220.
   PubMedGoogle Scholar
• Chiloeches, A., C. S. Mason, and R. Marais. 2001. S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3. Mol. Cell. Biol. 21: 2423–2434.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., and F. McCormick. 1993. Inhibition of cAMP of Ras-dependent activation of Raf. Science 262: 1069–1072.
   PubMed Web of Science ®Google Scholar
• de Rooij, J., and J. Bos. 1997. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14: 623–625.
   PubMed Web of Science ®Google Scholar
• Dhillon, A. S., S. Meikle, Z. Yazici, M. Eulitz, and W. Kolch. 2002. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21: 64–71.
   PubMed Web of Science ®Google Scholar
• Diaz, B., D. Barnard, A. Filson, S. MacDonald, A. King, and M. Marshall. 1997. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biolgical signalling. Mol. Cell. Biol. 17: 4509–4516.
   PubMed Web of Science ®Google Scholar
• Finney, R., and D. Herrera. 1995. Ras-Raf complexes: analyses of complexes formed in vivo. Methods Enzymol. 255: 310–323.
   PubMedGoogle Scholar
• Furth, M. E., L. J. Davis, B. Fleurdelys, and E. M. Scolnick. 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43: 294–304.
   PubMed Web of Science ®Google Scholar
• Hafner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14: 6696–6703.
   PubMedGoogle Scholar
• Hagemann, C., and U. R. Rapp. 1999. Isotype-specific functions of Raf kinases. Exp. Cell Res. 253: 34–46.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and E. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51–59.
   PubMed Web of Science ®Google Scholar
• Houslay, M. D., and W. Kolch. 2000. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58: 659–668.
   PubMedGoogle Scholar
• Houslay, M. D., and G. Milligan. 1997. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22: 217–224.
   PubMed Web of Science ®Google Scholar
• Hüser, M., J. Luckett, A. Chiloeches, K. Mercer, M. Iwobi, S. Giblett, X.-M. Sun, J. Brown, R. Marais, and C. Pritchard. 2001. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20: 1940–1951.
   PubMed Web of Science ®Google Scholar
• Jaumot, M., and J. F. Hancock. 2001. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20: 3949–3958.
   PubMed Web of Science ®Google Scholar
• Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351: 289–305.
   PubMed Web of Science ®Google Scholar
• L'Allemain, G., J. N. Lavoie, N. Rivard, V. Baldin, and J. Pouyssegur. 1997. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14: 1981–1990.
   PubMedGoogle Scholar
• Leevers, S. J., and C. J. Marshall. 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21 ras oncoprotein. EMBO J. 11: 569–574.
   PubMed Web of Science ®Google Scholar
• Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411–414.
   PubMed Web of Science ®Google Scholar
• Marais, R., Y. Light, C. Mason, H. Paterson, M. Olson, and C. J. Marshall. 1998. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280: 109–112.
   PubMed Web of Science ®Google Scholar
• Marais, R., Y. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14: 3136–3145.
   PubMed Web of Science ®Google Scholar
• Marais, R., Y. Light, H. F. Paterson, C. S. Mason, and C. J. Marshall. 1997. Differential regulation of Raf-1, A-Raf and B-Raf by oncogenic Ras and tyrosine kinases. J. Biol. Chem. 272: 4378–4383.
   PubMed Web of Science ®Google Scholar
• Marais, R., R. A. Spooner, Y. Light, J. Martin, and C. J. Springer. 1996. Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination. Cancer Res. 56: 4735–4742.
   PubMed Web of Science ®Google Scholar
• Marshall, C. 1999. How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Biol. 11: 732–736.
   Google Scholar
• Mason, C. S., C. Springer, R. G. Cooper, G. Superti-Furga, C. J. Marshall, and R. Marais. 1999. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18: 2137–2148.
   PubMed Web of Science ®Google Scholar
• McKenzie, F. R., and J. Pouyssegur. 1996. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J. Biol. Chem. 271: 13476–13483.
   PubMed Web of Science ®Google Scholar
• Milula, M., M. Schreiber, Z. Husak, L. Kucerova, J. Roth, R. Wieser, K. Zatloukal, H. Beug, E. Wagner, and M. Baccarini. 2001. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20: 1952–1962.
   PubMedGoogle Scholar
• Mischak, H., T. Seitz, P. Janosh, M. Eulitz, H. Steen, M. Schellerer, A. Philipp, and W. Kolch. 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16: 5409–5418.
   PubMedGoogle Scholar
• Morrison, D. K., G. Heidecker, U. R. Rapp, and T. D. Copeland. 1993. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268: 17309–17316.
   PubMedGoogle Scholar
• Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9: 180–186.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Sevetson, B. R., X. Kong, and J. C. J. Lawrence. 1993. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 90: 10305–10309.
   PubMed Web of Science ®Google Scholar
• Sidovar, M. F., P. Kozlowski, J. W. Lee, M. A. Collins, Y. He, and L. M. Graves. 2000. Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase. J. Biol. Chem. 275: 28688–28694.
   PubMed Web of Science ®Google Scholar
• Stokoe, D., S. G. Macdonald, K. Cadwallader, M. Symons, and J. F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science 264: 1463–1467.
   PubMed Web of Science ®Google Scholar
• Tortora, G., F. Ciardiello, S. Ally, T. Clair, D. S. Salomon, and Y. S. Cho-Chung. 1989. Site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts. FEBS Lett. 242: 363–367.
   PubMed Web of Science ®Google Scholar
• Weissinger, E. M., G. Eissner, C. Grammer, S. Fackler, B. Haefner, L. S. Yoon, K. S. Lu, A. Bazarov, J. M. Sedivy, H. Mischak, and W. Kolch. 1997. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol. Cell. Biol. 17: 3229–3241.
   PubMedGoogle Scholar
• Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1069.
   PubMed Web of Science ®Google Scholar
• Zhang, B. H., and K. L. Guan. 2000. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19: 5429–5439.
   PubMed Web of Science ®Google Scholar
• Zimmermann, S., and K. Moelling. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286: 1741–1744.
   PubMed Web of Science ®Google Scholar